Tcmc

tcmc is a biotechnology company specializing in the field of cell and gene therapy, offering comprehensive contract development and manufacturing (CDMO) services. We provide IND-enabling CMC development, as well as clinical and commercial manufacturing solutions. With expertise in large-scale process development, GMP manufacturing, and vectorology development, tcmc has built a robust and versatile production platform to support a wide range of cell and gene therapy products. Backed by policy and regulatory support, we are committed to accelerating development timelines while reducing manufacturing costs for our clients. At tcmc, excellence is our DNA. We specialize in delivering premium-quality viral vectors, particularly in lentiviral vectors (LVVs), and cell therapy products tailored to meet your needs. LVVs play an important role in genetic engineering of T cells (e.g. Chimeric Antigen Receptor T/CAR-T), and we offer advanced solutions for LVV manufacturing to support gene-editing T cells, from R&D to full-scale commercialization. But that’s not all—our expertise extends to the manufacturing of non-genetically modified cells as well, including DC, CIK, NK and stem cells. Furthermore, we understand the complex world of compliance, so every CDMO service we provide is accompanied by robust regulatory support for your CMC package. From groundbreaking research to life-changing therapies, tcmc is your trusted partner in developing next generation therapies. Let’s advance the future of healthcare together.